Sectors & IndustriesHealthcareDrug Manufacturers - Specialty & Generic

Best Pharmaceutical Stocks to Buy Now (2023)

Top pharmaceutical stocks in 2023 ranked by overall Zen Score. See the best pharmaceutical stocks to buy now, according to analyst forecasts for the drug manufacturers - specialty & generic industry.

According to Zen Score, the 3 best pharma stocks to buy right now are:

Siga Technologies (NASDAQ:SIGA) is the top pharmaceutical stock with a Zen Score of 68, which is 40 points higher than the pharmaceutical industry average of 28. It passed 26 out of 38 due diligence checks and has strong fundamentals. Siga Technologies has seen its stock lose -56.92% over the past year, underperforming other pharmaceutical stocks by -41 percentage points.

Phibro Animal Health (NASDAQ:PAHC) is the second best pharmaceutical stock with a Zen Score of 60, which is 32 points higher than the pharmaceutical industry average of 28. It passed 21 out of 38 due diligence checks and has strong fundamentals. Phibro Animal Health has seen its stock lose -10.67% over the past year, overperforming other pharmaceutical stocks by 6 percentage points.

Phibro Animal Health has an average 1 year price target of $19.00, an upside of 51.27% from Phibro Animal Health's current stock price of $12.56.

Phibro Animal Health stock has a consensus Buy recommendation according to Wall Street analysts. Of the 2 analysts covering Phibro Animal Health, 50% have issued a Strong Buy rating, 0% have issued a Buy, 50% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

Assertio Holdings (NASDAQ:ASRT) is the third best pharmaceutical stock with a Zen Score of 60, which is 32 points higher than the pharmaceutical industry average of 28. It passed 19 out of 33 due diligence checks and has strong fundamentals. Assertio Holdings has seen its stock return 16.52% over the past year, overperforming other pharmaceutical stocks by 33 percentage points.

Assertio Holdings has an average 1 year price target of $7.50, an upside of 187.36% from Assertio Holdings's current stock price of $2.61.

Assertio Holdings stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 2 analysts covering Assertio Holdings, 50% have issued a Strong Buy rating, 50% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

Out of 7 pharmaceutical stocks that have issued dividends in the past year, the 3 pharmaceutical stocks with the highest dividend yields are:

Siga Technologies (NASDAQ:SIGA) has an annual dividend yield of 9.57%, which is 6 percentage points higher than the pharmaceutical industry average of 3.12%.

Siga Technologies's dividend payout ratio of 118.4% indicates that its high dividend yield might not be sustainable for the long-term.

Phibro Animal Health (NASDAQ:PAHC) has an annual dividend yield of 3.82%, which is 1 percentage points higher than the pharmaceutical industry average of 3.12%. Phibro Animal Health's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Phibro Animal Health's dividend has shown consistent growth over the last 10 years.

Phibro Animal Health's dividend payout ratio of 59.3% indicates that its dividend yield is sustainable for the long-term.

Perrigo Co (NYSE:PRGO) has an annual dividend yield of 3.23%, which is the same as the pharmaceutical industry average of 3.12%. Perrigo Co's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Perrigo Co's dividend has shown consistent growth over the last 10 years.

Perrigo Co's dividend payout ratio of -213.2% indicates that its dividend yield might not be sustainable for the long-term.

Pharmaceutical stocks were down -0.13% in the last day, and down -1.46% over the last week. Canopy Growth was the among the top losers in the drug manufacturers - specialty & generic industry, dropping -15.34% yesterday.

Canopy Growth shares are trading lower after the company filed for an offering of up to 45.9 million shares of common stock by the selling securityholders.

Based on WallStreetZen's Valuation Score, the 3 most undervalued pharmaceutical stocks right now are:

Assertio Holdings (NASDAQ:ASRT) is the most undervalued pharmaceutical stock based on WallStreetZen's Valuation Score. Assertio Holdings has a valuation score of 100, which is 75 points higher than the pharmaceutical industry average of 25. It passed 7 out of 7 valuation due diligence checks.

Assertio Holdings's stock has gained 16.52% in the past year. It has overperformed other stocks in the pharmaceutical industry by 33 percentage points.

Viatris (NASDAQ:VTRS) is the second most undervalued pharmaceutical stock based on WallStreetZen's Valuation Score. Viatris has a valuation score of 86, which is 61 points higher than the pharmaceutical industry average of 25. It passed 6 out of 7 valuation due diligence checks.

Viatris's stock has gained 9.29% in the past year. It has overperformed other stocks in the pharmaceutical industry by 26 percentage points.

Siga Technologies (NASDAQ:SIGA) is the third most undervalued pharmaceutical stock based on WallStreetZen's Valuation Score. Siga Technologies has a valuation score of 86, which is 61 points higher than the pharmaceutical industry average of 25. It passed 6 out of 7 valuation due diligence checks.

Siga Technologies's stock has dropped -56.92% in the past year. It has underperformed other stocks in the pharmaceutical industry by -41 percentage points.